| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 08/17/2006 | US20060183908 Heterocyclic compounds, methods of making them and their use in therapy |
| 08/17/2006 | US20060183875 Novel fluorinated dioxolan compound and novel fluorinated polymer |
| 08/17/2006 | US20060183749 Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 08/17/2006 | US20060183046 Novel coloring compound and recording material using the same |
| 08/17/2006 | US20060179585 Sulfonamide derviatives of polycyclic dyes used for analytical applications |
| 08/17/2006 | CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/17/2006 | CA2594662A1 Mitotic kinesin inhibitors |
| 08/16/2006 | EP1690854A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 08/16/2006 | EP1689743A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 08/16/2006 | EP1689742A1 Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
| 08/16/2006 | EP1689741A1 Benzoyl amino pyridyl carboxylic acid derivatives as glucokinase activators |
| 08/16/2006 | EP1689729A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 08/16/2006 | EP1689722A2 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 08/16/2006 | EP1689721A1 Aminopyrazole derivatives as gsk-3 inhibitors |
| 08/16/2006 | EP1689718A1 1-amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5 activity |
| 08/16/2006 | EP1689712A1 4-phenylpiperidine derivatives as renin inhibitors |
| 08/16/2006 | EP1689403A2 Heteroaryl-hydrazone compounds |
| 08/16/2006 | EP1689394A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 08/16/2006 | EP1689354A2 Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
| 08/16/2006 | EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 08/16/2006 | EP1487437B1 Use of selective ep4 receptor agonists for the treatment of diseases |
| 08/16/2006 | EP1432702B1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors |
| 08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 08/16/2006 | EP1261603B1 Flavone derivatives, preparation method and use as medicines |
| 08/16/2006 | EP0861236B2 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 08/16/2006 | CN1820004A Benzofuran derivatives and their use in the treatment of microbial infections |
| 08/16/2006 | CN1819998A Optically active halohydrin derivative and process for producing optically active epoxy alcohol derivative from the same |
| 08/16/2006 | CN1819995A Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 08/16/2006 | CN1819829A Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 08/16/2006 | CN1269814C Process and intermediates for pyridazinone antidiabetic agents |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269811C Piperazine derivatives having SST1 antagonistic activity |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/15/2006 | US7091353 Isoindole-imide compounds, compositions, and uses thereof |
| 08/15/2006 | US7091350 Produce powerful, particularly chromatic and bright colorations, in red tones, and which are relatively unselective and are stable to outside factors |
| 08/15/2006 | US7091349 Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091247 urotensin antagonists; vasoactive agents |
| 08/15/2006 | US7091237 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 08/15/2006 | US7091235 substituted with p-chlorobenzene and a pyrrolethoxybenzene; antitumor |
| 08/15/2006 | US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 08/15/2006 | US7091228 4-[4'-(1,3-Benzothiazol-2-ylamino)-1,1'-biphenyl-4-yl]-2,2-dimethyl-4-oxobutanoic acid and derivatives; inhibition of DGAT-1 (diacylglycerol O-acyltransferase type 1) |
| 08/15/2006 | US7091220 Substituted indole Mannich bases |
| 08/15/2006 | US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication |
| 08/15/2006 | US7091217 Chemokine receptor binding heterocyclic compounds |
| 08/15/2006 | US7091209 Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitors |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091200 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics |
| 08/15/2006 | US7090953 Organophotoreceptor with a charge transport compound having an epoxy group |
| 08/15/2006 | US7090902 Ink jet recording material |
| 08/15/2006 | CA2238376C Benzofuran carboxamides and sulphonamides |
| 08/15/2006 | CA2211612C [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides |
| 08/15/2006 | CA2201219C Process for the preparation of substituted pyrimidines |
| 08/10/2006 | WO2006083760A1 AMINO-PYRIDINES AS INHIBITORS OF β-SECRETASE |
| 08/10/2006 | WO2006083673A2 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006082392A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 08/10/2006 | WO2006082373A1 Pyrimidine compounds having ties (tek) inhibitory activity |
| 08/10/2006 | WO2006082354A1 Azacyclic compounds as inhibitors of sensory neurone specific channels ( sns ) |
| 08/10/2006 | WO2006082001A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | WO2006062982A3 Urea inhibitors of map kinases |
| 08/10/2006 | US20060178515 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 08/10/2006 | US20060178513 Pyridinylanilides |
| 08/10/2006 | US20060178429 2-Phenyl-3-hydrogenated furanyl, pyranyl, thiophenyl or thiopyranyl-N-heteroaromatic propionamides, e.g., 2-(3,4-Dichloro-phenyl)-3-(tetrahydro-pyran-2-yl)-N-thiazol-2-yl-propionamide; compounds increase insulin secretion in the treatment of type II diabetes. |
| 08/10/2006 | US20060178418 For therapy of asthma, bronchial asthma, chronic obstructive pulmonary disease, allergic rhinitis, eosinophilic granuloma, nephritis, rheumatoid arthritis, cystic fibrosis, chronic bronchitis, multiple sclerosis, Crohns disease, psoraisis, uticaria, adult vernal conjunctivitis, |
| 08/10/2006 | US20060178416 Quinoline derivatives as phosphodiesterase inhibitors |
| 08/10/2006 | US20060178415 Azole derivatives as antifungal agents |
| 08/10/2006 | US20060178412 [3-(Benzo[b]thiophene-2-carbonyl)-5-(4-methyl phenyl)-1H-indol-1-yl]-acetic acid, for treating conditions resulting from fibrinolytic disorders, such as deep vein thrombosis, coronary heart disease, and pulmonary fibrosis; Alzheimer's disease |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178405 Non-insulin dependent diabetes; 7-[2-(5-methyl-2-phenyl-4-oxazole)ethoxyl]-2-oxo-2H-1-benzopyran-3-carboxylic acid methyl ester; insulin-sensitizing activities |
| 08/10/2006 | US20060178403 Antiobesity agent, antidepressants, anxiolytic agents;3-[4-OXO-4H-THIENO[3,2-D]PYRIMIDIN-3-YL]-PYRROLIDINE-1-CARBOXYLIC ACID [1-(PYRROLIDIN-3-YL]-METHYL-AMIDES |
| 08/10/2006 | US20060178373 Oxy substituted flavones as antihyperglycemic and antidyslipidemic agents |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178369 Cinnamic acid amides |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060177457 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |
| 08/10/2006 | CA2597134A1 Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
| 08/10/2006 | CA2596636A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | CA2595834A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 08/10/2006 | CA2593857A1 Amino-pyridines as inhibitors of .beta.-secretase |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1688408A2 Vanilloid receptor ligands and their use in treatments |
| 08/09/2006 | EP1687289A1 Vitamin d receptor modulators |
| 08/09/2006 | EP1687277A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 08/09/2006 | EP1687269A1 Cosmetic process for preventing or treating the signs of skin ageing or the orange-peel appearance |
| 08/09/2006 | EP1687268A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 08/09/2006 | EP1687004A2 Pyridine compounds |
| 08/09/2006 | EP1687002A1 Fused heterocyclic compounds |
| 08/09/2006 | EP1686996A1 Quinazolinone compounds with reduced bioaccumulation |
| 08/09/2006 | EP1686990A2 2-guanidinylimidazolidinedione compounds and methods of making and using thereof |
| 08/09/2006 | EP1686987A2 Advanced indolinone based protein kinase inhibitors |
| 08/09/2006 | EP1597253B1 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 08/09/2006 | EP1483245B1 5-substituted-alkylaminopyrazole derivatives as pesticides |
| 08/09/2006 | EP1397361B1 Carboline derivatives as pdev inhibitors |
| 08/09/2006 | EP1317451B1 Chemokine receptor binding heterocyclic compounds |
| 08/09/2006 | EP1140828B1 3-azabicyclo¬3.1.0|hexane derivatives as opiate receptors ligands |
| 08/09/2006 | EP1060177B1 Method for producing doxazodin mesylate in a crystal modification designated as form a and intermediate product for producing the same |